Revolutionizing structural heart interventions through data-driven use of cardiac imaging
IF WE revolutionize structural heart interventions, can we improve clinical outcome and accelerate time to market?
FEops offers the first and only patient-specific simulation technology for structural heart interventions, surpassing basic anatomical measurement by accurately predicting how devices will interact with each unique patient. Our end-to-end solution adds value at every step in the structural heart product life cycle, helping manufacturers accelerate time to market and offering insights that help physicians achieve better patient outcomes.
FEops' cutting-edge technology transforms cardiac images into digital twins, virtual copies of the heart or its substructures. With this technology, FEops aims to improve and expand personalized treatment for patients with structural heart disease. It's FEops vision that combining digital twins with AI)enabled anatomical analyses generates data-driven insights aspring to enhance and improve procedure planning and periprocedural guidance. The CE-marked FEops HEARTguide™ technology enables healthcare professionals to improve both procedure efficiency and clinical outcomes. It also empowers Medtech copanies to bring superior products to the market faster than ever before.
FEops HEARTguide™, going beyond traditional procedure planning for structural heart interventions.
FEops HEARTguide™ simulations offer a detailed look at how a divice interacts with a specific patient before they ar even on the table. The insights revealed let the physician determine the optimal size and position for the device, helping to reduce risks and improve procedure efficiency.
FEops HEARTguide™ simulations gives more detailed insights than the current, manual "rigid-device overlay" technique to understand how a specific implant interacts with a patient's anatomy.
FEops HEARTguide™ is the only stand-alone, cloud-based platform that combines the advantages of digital twins with cutting-end AI technology for planning structural heart interventions.
More exciting innovations in the FEops pipeline
Besides the CE marked FEops HEARTguide™ platform for planning of TAVI and LAAo interventions, FEops is working on adding personalised simulations for replacement therapies for the different heart valves: transcatheter triscuspid valve replacement (TTVR).
Based on quality controlled, validated and AI-enabled anatomical analysis, FEops provides consistent and accurate data to optimize planning in mere minutes.
Fusion of FEops' simulations with live preoperative fluoroscopic images, bringing them inside the cath lab, and enabling the physiscian to position the device at the precise location that was determined preoperatively.
GOAL 3 : GOOD HEALTH AND WELL-BEING
FEops ensures healthy lives and promote well-being for all at all ages. FEops HEARTguide cloud-based procedure planning environment uses predictive simulation to provide clinicians and medical device manufacturers with first-ever insights into the interaction between transcatheter structural heart devices and specific patient anatomy –preoperatively
Do you think your project is the next big thing?
Join the team !